Development and biological investigations of hypoxia-sensitive prodrugs of the tyrosine kinase inhibitor crizotinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development and biological investigations of hypoxia-sensitive prodrugs of the tyrosine kinase inhibitor crizotinib

Published:2020-06 Issue: Volume:99 Page:103778
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Bielec Bjoern,Schueffl Hemma,Terenzi Alessio,Berger Walter,Heffeter Petra,Keppler Bernhard K.,Kowol Christian R.

Funder

Austrian Science Fund

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference30 articles.

1. Kinase-targeted cancer therapies: progress, challenges and future directions

2. Cardiovascular Toxic Effects of Targeted Cancer Therapies

3. Patient-derived models of acquired resistance can identify effective drug combinations for cancer

4. Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer

5. Trials and Tribulations of EGFR and MET Inhibitor Combination Therapy in NSCLC

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tailoring polymeric nanocarriers for hypoxia-specific drug release: Insights into design and applications in clinics;Chemical Engineering Journal;2024-09

2. Synthesis of 2‐Aminopyridine Derivatives via a Tandem CuAAC/Ring‐Cleavage/[4+2]‐Cycloaddition/Rearrangement Reaction Sequence;Advanced Synthesis & Catalysis;2024-08-07

3. Strategies for the development of stimuli-responsive small molecule prodrugs for cancer treatment;Frontiers in Pharmacology;2024-07-31

4. Recent Advances in the Application of Nitro(het)aromatic Compounds for Treating and/or Fluorescent Imaging of Tumor Hypoxia;Molecules;2024-07-25

5. Salts of Crizotinib with Dicarboxylic Acids: Structural Characteristic, Stability Analysis, and Solubility Performance;Crystal Growth & Design;2024-04-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3